Font Size Smaller Font Size
Larger Font Size
Latest Press Releases
-
September 12, 2018
OTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone
-
August 23, 2018
Celgene Corporation to Webcast at Upcoming Investor Conferences
-
July 26, 2018
Celgene Reports Second Quarter 2018 Operating and Financial Results
-
July 23, 2018
Celgene Announces Phase III ‘AUGMENT' Study of REVLIMID® in Combination with Rituximab (R²) for the Treatment of Patients with Relapsed/Refractory Indolent Lymphoma Met Primary Endpoint
-
July 10, 2018
Anti-PD-L1 Immunotherapy Plus ABRAXANE® Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study
No results found.